Literature DB >> 35473816

Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir.

.   

Abstract

Entities:  

Keywords:  Infections; Virus Diseases

Mesh：

Substances：

Year:  2022        PMID： 35473816     DOI： 10.1136/dtb.2022.000008

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN： 0012-6543


× No keyword cloud information.
  2 in total

1.  Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic.

Authors:  Giulia Garzi; Francesco Cinetto; Davide Firinu; Giulia Di Napoli; Gianluca Lagnese; Alessandra Punziano; Patrick Bez; Bianca Laura Cinicola; Giulia Costanzo; Riccardo Scarpa; Federica Pulvirenti; Marcello Rattazzi; Giuseppe Spadaro; Isabella Quinti; Cinzia Milito
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 2.  The Pharmacist's Role in Managing COVID-19 in Chronic Kidney Disease Patients: A Review of Existing Strategies and Future Implications.

Authors:  Mohammed Salim Karattuthodi; Shabeer Ali Thorakkattil; Suhaj Abdulsalim; Sathvik Belagodu Sridhar; Sainul Abideen Parakkal; Savera Arain; Hafees Madathil; Ajmal Karumbaru Kuzhiyil; Mamdouh Mohammed Ahmed Ageeli; Mazhuvanchery Kesavan Unnikrishnan
Journal:  Pharmacy (Basel)       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.